Global Cluster Headache Drug Market Analysis and Value Forecast Snapshot by EnPosted by Rashi Pande on December 18th, 2019 Market Analysis: Global Cluster Headache Drug MarketGlobal cluster headache drug market is expected to grow at a substantial CAGR of in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of cluster headaches, growing geriatric population, development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth. Key market players in the global cluster headaches market are F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc, AstraZeneca, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, TrioxBio Inc, Aurobindo Pharma, Endo Pharmaceuticals Inc, WOCKHARDT, Shanghai Soho Yiming Pharmaceutical Co., Ltd, Chengdu Tiantaishan pharmaceutical Co.,Ltd, electroCore, Inc, Autonomic Technologies, Inc, WINSTON PHARMACEUTICALS, Inc, CAPNIA, Inc and few others. Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cluster-headache-drug-market Market Definition: Global Cluster Headache Drug MarketCluster headache is also known as Horton’s syndrome is characterized by a series of relatively short but severe pain on one side of the head every day for weeks or months at a time. Headaches occur in form of clusters which means bouts of frequent attacks which may last from weeks to months and followed by long periods of relief. Cluster headaches occur at the same time each year because of their seasonal nature. Symptoms include nasal discharge, redness of eyes and excessive tearing. The prevalence rate of cluster headache is less than 1percent and mostly affects men. The attacks can begin at any age, although they usually occur between the ages of 20 and 40 years. The lifetime prevalence of cluster headache for adults of all ages was 124 per 100,000 or approximately 0.1 percent. Market Drivers
Market Restraints
Segmentation: Global Cluster Headache Drug MarketBy Types
By Mechanism of Action
By Drugs Type
By Diagnosis
By Treatment
By Route of Administration
By End-Users
By Geography
Key Developments in the Market:
Competitive Analysis: Global cluster headaches drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cluster headaches drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Like it? Share it!More by this author |